Mitsui Chemicals : Expansion of Electrolyte Solution Production Capacity for Taiwan JV
December 20, 2016 at 09:19 pm EST
Share
Formosa Mitsui Advanced Chemicals Co., Ltd. ('FMAC'), a joint venture of Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: Tsutomu Tannowa; 'Mitsui Chemicals') and Formosa Plastics Corporation (Taiwan: 1301; Chairman & President: Jason Lin; 'Formosa Plastics'), is to beef up the capacity of its lithium-ion, battery-use, electrolyte solution production facilities.
Demand for lithium ion batteries has expanded in line with the growth of the laptop, smartphone, and tablet device markets. In the future, greater market growth is forecast for the mobility market with the surge in demand for environment-friendly plug-in hybrid and electric vehicles especially in China.
Mitsui Chemicals, with Formosa Plastics, has exploited its extensive knowledge and cutting-edge technology to build high-quality production facilities for electrolyte solutions at FMAC to meet the needs of an expanding Chinese market, with operations commencing in July 2016. This latest plan for FMAC will expand production and supply systems in preparation for further market growth. Below is an outline of FMAC and the planned expanded production capacity.
Outline of FMAC and planned expanded production capacity
1. Name
Formosa Mitsui Advanced Chemicals Co., Ltd.
2. Establishment
August 2013
3. Capital
US$ 8.2 million
4. Equity ratio
Mitsui Chemicals 50%, Formosa Plastics 50%
5. Location
FPC industrial complex in Ningbo, China
6. Business
anufacture, sales and research for electrolyte solution in China
7. Capacity
1500 tons / year
(commercial operations commenced July 2016)
8. Planned expanded production capacity
Following expansion: +3,500 tons / year (to be 5,000 tons / year)
Construction Start scheduled: December 2016
Commercial operations scheduled: November 2017
Demand for lithium-ion battery-use electrolyte solution is also forecast to grow in Japan, especially for onboard equipment. Mitsui Chemicals established a production facility for 5,000 tons/year at Nagoya Works in October 2016, with commercial operations scheduled to commence in April 2017.
The Company has targeted the mobility domain as a growth driver. As one of the growth leaders in this domain, Mitsui Chemicals is actively pursuing development in the area of lithium-ion battery-use electrolyte solutions. Mitsui Chemicals will further strengthen its electrolyte solution business by expanding its production and supply systems in China and Japan.
<Outline of Formosa Plastics>
1. Name
FORMOSA PLASTICS CORPORATION
2. Establishment
November 1954
3. Capital
US$ 1,930 million
4. Location
201 Tung Hwa N. Road Taipei, Taiwan
5. Business
Manufacture and sales of petrochemicals and chemical products
6. Employees
6,024 (2015)
Attachment
Expansion of Electrolyte Solution Production Capacity for Taiwan JV
Mitsui Chemicals enhances mobility business to capture share in China's environment-friendly car market (PDF : 339KB)
Mitsui Chemicals Inc. published this content on 21 December 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 December 2016 02:18:11 UTC.
Original documenthttp://www.mitsuichem.com/release/2016/161221.htm
Public permalinkhttp://www.publicnow.com/view/B830CEB73E4FD6740F6A0E1B3BC7B46BE69E0E36
Mitsui Chemicals, Inc. specializes in the manufacture and marketing of chemicals products. Net sales break down by product family as follows:
- basic chemicals and fine chemicals products (48.8%): polypropylene, polyethylene, phenols, polyolefins, polyurethane, etc.;
- performance chemicals products (25.5%): elastomers, urethane, polymers, etc. intended in particular for the automotive industry;
- coating materials, films and agrochemicals (14.6%): resins, adhesives, polypropylene films, polyethylene films, industrial films, agrochemicals (insecticides, fungicides, herbicides, etc.) for the food and packaging sectors;
- specialty materials (10.2%): ophthalmic lens materials, photochromic materials, non-woven fibers, dental products, etc. dedicated to the medical and healthcare industry;
- other (0.9%).
Net sales are distributed geographically as follows: Japan (52.2%), China (14.5%), Asia (13.6%), America (11.8%), Europe (7.3%) and other (0.6%).